International adaptation and use of NCCN Guidelines

Ali Bazarbachi; Andrew D Zelenetz

doi:10.6004/jnccn.2014.0203

International adaptation and use of NCCN Guidelines

J Natl Compr Canc Netw. 2014 May;12(5 Suppl):838-41. doi: 10.6004/jnccn.2014.0203.

Authors

Ali Bazarbachi¹, Andrew D Zelenetz¹

Affiliation

¹ Presented by Ali Bazarbachi, MD, PhD, Professor of Medicine, Associate Dean for Basic Research, Director, Bone Marrow Transplantation Program, Faculty of Medicine, American University of Beirut, Beirut, Lebanon, and Andrew D. Zelenetz, MD, PhD, Professor of Medicine, Weill Medical College of Cornell University, and Vice Chair, Medical Informatics, Department of Medicine, and Attending Physician in the Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York City, New York.

PMID: 24853230
DOI: 10.6004/jnccn.2014.0203

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) describe a continuum of cancer care in the United States, from initial diagnosis through treatment and referral to hospice beyond treatment. However, in many other countries, there are no regional or national clinical practice guidelines. In 2008, the NCCN-MENA (Middle East and North Africa) project was launched to adapt the NCCN Guidelines to this part of the world. During their joint presentation at the NCCN 19th Annual Conference, Dr. Ali Bazarbachi and Dr. Andrew D. Zelenetz explored the modification process of NCCN Guidelines for MENA and shared examples of how it improved the care of patients with adult T-cell leukemia or lymphoma and younger patients with diffuse large B-cell lymphoma-regardless of where they live.

Publication types

Editorial

MeSH terms

Africa, Northern
Humans
Medical Oncology / standards*
Middle East
Practice Guidelines as Topic*
United States